Prediabetes Market: Current Analysis and Forecast (2025-2033)

Emphasis on Product Type (Diagnostics & Devices, Pharmaceuticals & Therapeutics, Nutraceuticals & Functional Foods, and Others); Age Group (Children, Adults, and Elderly); End User (Hospitals & Clinics, Diagnostic Centers, Homecare Settings, and Others); and Region/Country

Geography:

Global

Industry:

Healthcare

Last updated:

Apr 2025

Global Prediabetes Market Size & Forecast

Global Prediabetes Market Size & Forecast

The Global Prediabetes Market was valued at USD 311.3 million in 2024 and is expected to grow to a strong CAGR of around 10.02% during the forecast period (2025-2033F), driven by rising global prevalence of obesity and sedentary lifestyles, which significantly increase the risk of type 2 diabetes.

Prediabetes Market Analysis

The prediabetes market is significantly progressing because of the increasing rates of its prevalence, the augmentation of awareness about the disease, and the changing trends in the global focus on preventive medicine. A sedentary lifestyle, improper diet, and increased prevalence of obesity have been emerging factors for the rise in the incidence of prediabetes, primarily in urban communities. Growing awareness of the risky consequences of untreated prediabetes, such as the development of type 2 diabetes and cardiovascular diseases, is driving early intervention strategies among patients and helping in the prediabetes treatment. Moreover, frequent physical checkups and modifications in lifestyle, such as having a prediabetes diet, represent two aspects that governments and other healthcare-related bodies are continuously encouraging, thus driving the market growth.

Global Prediabetes Market Trends

This section discusses the key market trends that are influencing the various segments of the global prediabetes market, as found by our team of research experts.

Rise in At-Home Testing Kits

Convenience and privacy are the biggest concerns that help to increase the popularity of at-home testing kits for prediabetes. These kits enable patients to test their blood glucose levels or HbA1c without the need for professional help, as well as by blood samples from a fingertip or saliva. The current advancement of smartphones and electronic health platforms enables users to get immediate feedback as well as consult with medical practitioners through technology, which further helps in the prediabetes treatment. This is especially so in rural or other areas that may not be within proximity of a diagnostic centre accessibility. As the general health consciousness of the population grows and as more and more people transition to online connections, more people are getting themselves tested early so they can correct their lifestyles sooner, start prediabetes medication, and are able to reverse prediabetes.  Moreover, key players are engaging in launching innovative home kit solutions to discover the early signs of prediabetes.

Prediabetes Industry Segmentation

This section provides an analysis of the key trends in each segment of the global prediabetes market report, along with forecasts at the global, regional, and country levels for 2025-2033.

Diagnostics & Devices Segment Dominates the Prediabetes Market.

Based on product type, the market is segmented into diagnostics & devices, pharmaceuticals & therapeutics, nutraceutical & functional foods, and others. Among these, the diagnostics & devices segment has the highest market share. This dominance is due to the growing number of tools for early detection of diabetes, heightened consciousness among people about prediabetes management, and the increased use of blood glucose monitors, HbA1c testing kits, and CGM devices. However, the nutraceuticals & functional foods sector is expected to grow at the fastest rate in the future, due to the shift towards using natural healthcare solutions, and the use of dietary supplements and functional foods to control blood sugar levels.

Hospitals & Clinics Segment Dominates the Prediabetes Market.

Based on the end-user category, the global market is categorized into hospitals & clinics, diagnostic centers, homecare settings, and others. Among these, the hospitals & clinics segment has the largest market share. Major factors are increased patients' visits to hospitals, availability of enhanced diagnostic laboratories, and healthcare practitioners' specialization in early identification and treating prediabetes symptoms. However, the homecare settings segment is expected to show the highest CAGR in the future. This is due to the increase in the use of personal health monitoring devices, knowledge of preventive care, and developments in telemedicine and remote patient monitoring facilities.

Prediabetes Market Segment

The North America region holds a significant market share in the Global Prediabetes Market.

North America has a higher market demand for prediabetes due to factors such as a high prevalence of prediabetes, a well-developed healthcare sector, and increased awareness regarding early diagnosis and prevention. The North American population benefits from the ease of accessibility to diagnostics, digital health solutions, and lifestyle modification plans to facilitate early diagnosis and control. Additionally, government programs such as the National Diabetes Prevention Program (NDPP) under the Centers for Disease Control (CDC) also act as a driving force to enhance screening and awareness strategies. Moreover, high insurance penetration, better healthcare expenditure, and affiliations between healthcare and technology companies also contribute to market growth. Consumer awareness and adoption of wearable health devices also pave the way towards the increased market dominance of the region.

The U.S. held a Dominant share of the North American Prediabetes Market in 2024

The largest market for prediabetes is in the United States, as it has a large patient pool, the adoption of innovative health care technologies, and mainly increased government attention to preventive health care. Increased prevalence of the disease in the population, the use of screening tests such as HbA1c and CGM, and the timely diagnosis help to prevent the development of complications. Furthermore, the market’s strategic presence of large market stakeholders and large investments in digital therapeutics and health platforms based on artificial intelligence increases the country’s market potential. Other favorable reimbursement policies and public and private partnerships add to the app's accessibility to prediabetes management solutions, making the US the leading nation in the region.

Prediabetes Market Trends

Prediabetes Industry Competitive Landscape

The global prediabetes market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, geographical expansions, and mergers and acquisitions.

Top Prediabetes Product Manufacturing Companies

Some of the major players in the market are Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Ascensia Diabetes Care, Omada Health, Noom, Inc., Eli Lilly and Company, PharmaLinea, Oramed, and Bayer AG.

Recent Developments in the Prediabetes Market

  • In August 2024 – Eli Lilly and Company announced the positive topline results from the SURMOUNT-1 three-year study (176-week treatment period) evaluating the efficacy and safety of tirzepatide. This drug is expected to reduce the risk of developing type 2 diabetes by 94% in adults with pre-diabetes and obesity or overweight.

  • In March 2023 – PharmaLinea launched “Prediabetiq Capsules,” a clinically supported private label food supplement designed to provide immediate improvement in glycemic response, measurable in real-time. The product was formulated with patented, award-winning, and clinically studied ingredients aimed at promoting balanced blood glucose levels and reducing insulin resistance.

Global Prediabetes Market Report Coverage

Report Attribute

Details

Base year

2024

Forecast period

2025-2033

Growth momentum 

Accelerate at a CAGR of 10.02%

Market size 2024

USD 311.3 Million

Regional analysis

North America, Europe, APAC, Rest of the World

Major contributing region

Asia-Pacific is expected to dominate the market during the forecast period.

Key countries covered

U.S., Canada, Germany, U.K., Spain, Italy, France, China, Japan, and India

Companies profiled

Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Ascensia Diabetes Care, Omada Health, Noom, Inc., Eli Lilly and Company, PharmaLinea, Oramed, and Bayer AG

Report Scope

Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Demand and Supply Side Analysis; Competitive Landscape; Company Profiling

Segments Covered

By Product Type, By Age Group, By End-user, By Region/Country

Reasons to Buy the Prediabetes Market Report:

  • The study includes market sizing and forecasting analysis confirmed by authenticated key industry experts.

  • The report briefly reviews overall industry performance at a glance.

  • The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, type portfolios, expansion strategies, and recent developments.

  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

  • The study comprehensively covers the market across different segments.

  • Deep dive regional level analysis of the industry.

Customization Options:

The global Prediabetes market can further be customized as per the requirements or any other market segment. Besides this, UnivDatos understands that you may have your own business needs, hence feel free to contact us to get a report that completely suits your requirements.

Table of Contents

Research Methodology for the Global Prediabetes Market Analysis (2023-2033)

We analyzed the historical market, estimated the current market, and forecasted the future market of the global prediabetes market to assess its application in major regions worldwide. We conducted exhaustive secondary research to gather historical market data and estimate the current market size. To validate these insights, we carefully reviewed numerous findings and assumptions. Additionally, we conducted in-depth primary interviews with industry experts across the prediabetes value chain. After validating market figures through these interviews, we used both top-down and bottom-up approaches to forecast the overall market size. We then employed market breakdown and data triangulation methods to estimate and analyze the market size of industry segments and sub-segments.

Market Engineering

We employed the data triangulation technique to finalize the overall market estimation and derive precise statistical numbers for each segment and sub-segment of the global prediabetes market. We split the data into several segments and sub-segments by analyzing various parameters and trends, including product type, age group, end-user, and regions within the global prediabetes market.

The Main Objective of the Global Prediabetes Market Study

The study identifies current and future trends in the global prediabetes market, providing strategic insights for investors. It highlights regional market attractiveness, enabling industry participants to tap into untapped markets and gain a first-mover advantage. Other quantitative goals of the studies include:

  • Market Size Analysis: Assess the current and forecast market size of the global prediabetes market and its segments in terms of value (USD).

  • Prediabetes Market Segmentation: Segments in the study include areas of product type, age group, end-user, and region.

  • Regulatory Framework & Value Chain Analysis: Examine the regulatory framework, value chain, customer behavior, and competitive landscape of the prediabetes industry.

  • Regional Analysis: Conduct a detailed regional analysis for key areas such as Asia Pacific, Europe, North America, and the Rest of the World.

  • Company Profiles & Growth Strategies: Company profiles of the prediabetes market and the growth strategies adopted by the market players to sustain in the fast-growing market.

Frequently Asked Questions FAQs

Q1: What is the global prediabetes market’s current market size and growth potential?

Q2: Which segment has the largest share of the global prediabetes market by product type?

Q3: What are the driving factors for the growth of the global prediabetes market?

Q4: What are the emerging technologies and trends in the global prediabetes market?

Q5: What are the key challenges in the global prediabetes market?

Q6: Which region dominates the global prediabetes market?

Q7: Who are the key companies in the global prediabetes market?

Q8: What are the key investment opportunities in the global prediabetes market?

Q9: What regulatory and reimbursement trends are shaping the prediabetes industry?

Related Reports

Customers who bought this item also bought

Private Health Insurance Market: Current Analysis and Forecast (2024-2032)

Private Health Insurance Market: Current Analysis and Forecast (2024-2032)

Emphasis on Age Group (Senior Citizens, Adults, and Minors); Distribution channel (Direct Sales, Brokers/Agents, Banks, and Others); and Region/Country

June 20, 2024

India Catheter Market: Current Analysis and Forecast (2024-2032)

India Catheter Market: Current Analysis and Forecast (2024-2032)

Emphasis on Product Type (Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, and Specialty Catheters); Material Type (Silicone, Polyurethane, Latex, and Others); Region

November 4, 2024

Blood Pressure Cuffs Market: Current Analysis and Forecast (2024-2032)

Blood Pressure Cuffs Market: Current Analysis and Forecast (2024-2032)

Emphasis on Product Type (Manual, Automated), Usage Type (Reusable, Disposable), End-user (Hospitals, Home and Others); and Region/Country

October 16, 2024

Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)

Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)

Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country

October 8, 2024